FeesSafety
Pluang+

Assured Guaranty stock hits 52-week low amid mixed analyst views and Brightline restructuring.

Market News
25 Sep 2026, 20:01 WIB
Alex Lavoie
View Source
Neutral
Assured Guaranty stock hits 52-week low amid mixed analyst views and Brightline restructuring.

Assured Guaranty Ltd. (NYSE: AGO) saw its stock price pressured to a new 52-week low of $68.04 despite a recent upgrade to "Buy" by Roth Capital. The company is involved in the financial restructuring of Brightline Florida, where a subsidiary insured bonds now under Chapter 11 protection. Analyst opinions vary, with some maintaining outperform ratings but lowering price targets, while others have downgraded the stock. This mixed sentiment reflects uncertainty about the company's future amid ongoing market challenges.

Assured Guaranty Ltd. stock is under pressure amid mixed analyst ratings. For readers following Financials, here is Pluang's market snapshot as of Sep 25, 2026 20:51 WIB: Of 85 priced Financials-sector US stocks, 46 rose and 35 fell. Key movers include CLSK at USD 13.85 with a -2.88% change, RIOT at USD 22.82 with a -2.81% change and 100% sell order activity, and BTBT at USD 1.74 with a -2.79% change and 57% sell order activity.

More News

Organic Grower Summit 2026 adds live ag tech demos at Reservoir Farms for hands-on grower experience

Organic Grower Summit 2026 adds live ag tech demos at Reservoir Farms for hands-on grower experience

The Organic Grower Summit (OGS) 2026, held Dec. 2–3 in Monterey, California, introduces an exclusive offsite AGTech Reception & Field Demos at Reservoir Farms. Sponsored by John Deere, Western Growers Association, and Reservoir, this event offers gro...

Others
Bullish
50 minutes ago
New brain cancer drug data and trials spotlighted at Society for Neuro-Oncology meeting

New brain cancer drug data and trials spotlighted at Society for Neuro-Oncology meeting

At the 31st Annual Society for Neuro-Oncology meeting, biotech firms NeOnc, Nuvation Bio, Jazz Pharmaceuticals, and Cerenome presented new clinical data on brain cancer treatments. Highlights include NeOnc's NEO100 and NEO212 therapies advancing towa...

Market News
Bullish
1 hour ago
Subsea 7 wins $50M-$150M contract for deepwater project in US Gulf of Mexico starting 2028

Subsea 7 wins $50M-$150M contract for deepwater project in US Gulf of Mexico starting 2028

Subsea 7 has secured a sizeable contract from Kosmos Energy for the Tiberius Project in the US Gulf of Mexico, involving fabrication and installation of subsea infrastructure at about 2,200 meters depth. The work includes a 14-kilometer steel riser, ...

Market News
Bullish
1 hour ago
GlobeNewswire issues daily market update with no new financial news on Nov 13, 2026

GlobeNewswire issues daily market update with no new financial news on Nov 13, 2026

GlobeNewswire released its End of Day Message for November 13, 2026, confirming its role as an FCA-approved primary information provider. The update mainly reiterates its operational status and disclaimers, without reporting any new financial events ...

Market News
Neutral
1 hour ago
Space42 reports 11% revenue growth and 30% jump in normalized EBITDA for first nine months of 2026

Space42 reports 11% revenue growth and 30% jump in normalized EBITDA for first nine months of 2026

Space42, a UAE-based space technology company, announced strong financial results for the first nine months of 2026, with revenue up 11% to $404 million and normalized EBITDA rising 30% to $194 million. Growth was driven by its two main divisions: Sp...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App